KTRA's logo.
Ticker Symbol: KTRA

Kintara Therapeutics Inc

$0.84 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001498382

Company Profile

Kintara Therapeutics, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. Kintara Therapeutics serves customers worldwide.

Sector: Manufacturing
Industry: Polish and Other Sanitation Good Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 12707 High Bluff Drive
CEO: Saiid Zarrabian
Tags:
  • Distribution Services
  • Wholesale Distributors
  • Manufacturing
  • Polish and Other Sanitation Good Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $3.87
Change: $0.00 ( -0.13%)
Days Range: $3.87 - $4.21
Beta: 0.44
52wk. High: $15.50
52wk. Low: $2.70
Ytd. Change -43.89%
50 Day Moving Average: $3.98
200 Day Moving Average: $3.73
Shares Outstanding: 1746408

Valuation

Market Cap: 675.9M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A